Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q2 2026 · 10-Q
Revenue$44.78M$44.78M+215.0% vs Q2 2025 Net Income$55.67M$55.67M+50.5% vs Q2 2025 EPS Diluted$1.15$1.15+45.6% vs Q2 2025 Operating Cash Flowderived$64,973,000+8.6% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end